All lobbying filings

CAPITOL HILL CONSULTING GROUP

CAPITOL HILL CONSULTING GROUP filed a Q3 report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC on October 20, 2026, reporting $80,000 in lobbying income.

Lobbying for CHARLES RIVER LABORATORIES INTERNATIONAL, INC · Contract Research Organization

All filings by CAPITOL HILL CONSULTING GROUP · Everything CHARLES RIVER LABORATORIES INTERNATIONAL, INC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 3

BRIAN SUTTER

Previously held: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
CHRISTOPHER DAVIS

Previously held: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).
EMILY ELIZABETH WILKINSON-HOLLAND

Previously held: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups

Food Industry (safety, labeling, etc.)

Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Pharmacy

Issues surrounding improvements to clinical research capabilities and modernization of research methods.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.